{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

GreenEnergyBreaks — Eco Wave Power Global AB (NASDAQ: WAVE) Reports March 2026 Production Results from Jaffa Pilot Project

April 7, 2026Eco Wave Power (NASDAQ: WAVE), a global leader in onshore wave energy technology, reported that its EWP-EDF One pilot project at Jaffa Port in Israel generated more than 1,200 kWh of renewable electricity during March 2026, with approximately six days of moderate wave conditions ranging from 1 to 2 meters. The results highlight the system’s ability to efficiently convert commonly occurring sea states into power, reinforcing its potential as a reliable energy solution for coastal infrastructure and AI-driven data center demand while continuing to demonstrate stable, zero-downtime operations since early 2025.


Study Explores Whether a Common Vitamin Could Fight Brain Cancer

April 7, 2026Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds promise in restoring immune function in the fight against glioblastoma, a brain cancer that grows aggressively and is hard to treat. It remains to be seen whether clinical studies involving larger numbers of patients confirm what these early studies have shown about the benefits of using niacin alongside radiotherapy and chemotherapy to boost treatment outcomes.


Israel Uses AI to Upgrade its Public Alert System

April 7, 2026Civil defense authorities in Israel have been working to improve the alert system depended upon to get people into shelters before incoming projectiles hit. AI is playing a key role in improving that alert system.


AI Creates Skills Gap in Investment Banking

April 7, 2026Artificial intelligence is quickly changing the way investment banking works, and while this shift brings clear benefits, it is also creating new challenges. One of the biggest concerns today is the growing skills gap among junior bankers as AI takes over many of their traditional responsibilities.


US Motorists are Embracing Chinese Electric Vehicles

April 7, 2026Chinese electric vehicles remain locked out of the American market, but the appetite for them keeps growing. Tariffs introduced under the Biden administration pushed duties past 100%, sealing the border to Chinese EVs.


Japanese Engineers Tap Wastewater to Produce Clean Energy

April 7, 2026A water treatment facility in Japan is exploring a novel form of renewable energy by tapping into the natural process of osmosis. This process, where water moves from a less concentrated solution to a more concentrated one, has long been understood.


AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

April 7, 2026AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (“AI”) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (“GMP”) standards.


Renewables Surge by Almost 700 GW in 2025

April 7, 2026Renewable energy capacity expanded by nearly 700 gigawatts last year as geopolitical turbulence continued to make the case for accelerating the transition to clean energy. With Middle East tensions continuing to rattle fossil fuel markets, nations are increasingly treating clean energy as a strategic shield against supply disruptions, not just a climate commitment.


MissionIRNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Secures Up to $20 Million Financing Agreement

April 7, 2026TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage company focused on immuno-oncology and RNA-based therapies, announced that it has entered into a financing agreement with an institutional healthcare investor for up to $20 million. The arrangement includes up to $6 million in pre-paid advances and a three-year Standby Equity Purchase Agreement allowing the company to sell up to $14 million in common stock, providing financial flexibility to support its Phase 2a trial of lead candidate TTX-MC138 and ongoing operations.


AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities

April 7, 2026AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination control, data integrity and operational traceability. The European Union’s revised GMP Annex 1 emphasizes minimizing human intervention and implementing a comprehensive contamination control strategy, requiring manufacturers to assess and mitigate contamination risks across personnel, processes and environments.


TechMediaBreaks – Versus Systems Inc. (NASDAQ: VS) Engages IBN for Corporate Communications Strategy

April 7, 2026Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has engaged IBN to support its corporate communications strategy. Through the partnership, IBN will leverage its expansive investor-focused distribution network to increase awareness of Versus Systems, whose platform enables interactive audience participation and real-world rewards across digital and live environments, serving brands, sports leagues and entertainment partners globally.


AINewsBreaks – Micropolis AI Robotics (NYSE: MCRP) to Participate in Maxim Group AI Infrastructure Virtual Conference

April 7, 2026Micropolis AI Robotics (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven autonomous mobility solutions, announced that Founder and CEO Fareed Aljawhari will participate in a fireside chat at Maxim Group’s AI Infrastructure Virtual Conference, “Powering the AI Revolution – Building the Infrastructure Behind Generative AI,” taking place today, April 7, 2026, at 4:00 p. m.


PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances IP Portfolio With EPO Notice of Intent to Grant Patent

April 7, 2026Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, announced that the European Patent Office has issued a Rule 71(3) communication indicating its intent to grant a patent covering methods of preventing stress-induced fear and depressive-like behavior using serotonin 4 (5-HT4) receptor agonists. The patent, exclusively licensed from Columbia University, is expected to strengthen the company’s intellectual property position across major European markets as Silo advances its pipeline targeting stress-related and central nervous system disorders.